Ekkehard May

Ekkehard May has a comprehensive work experience in the pharmaceutical and medical field. Starting in 2020, they are currently the Head of Cross Indication Research at Nuvisan Pharma Services. Prior to that, they held various roles at Bayer Pharmaceuticals, including Head of Cross Indication Research from 2005-2020, Senior Scientist and Head of Laboratory in Indication Expansion from 2007-2020, and Head of Laboratory in Inflammation & Immunology from 2005-2007. Before joining Bayer, they worked at Schering AG as a Research Group Leader in CRBA Dermatology from 2004-2005 and as a Postdoctoral Scientist in Dermatology from 2003-2004. Ekkehard also served as a Wiss. Assistent at Ludwig-Maximilians Universität München from 2002-2003, a Postdoctoral Fellow at UT Southwestern Medical Center at Dallas from 1999-2001, a Postdoctoral research fellow at Saarland University from 1998-1999, and a PhD student at University Medicine of the Johannes Gutenberg-University Mainz from 1994-1998.

Ekkehard May attended Johannes Gutenberg University Mainz from 1988 to 1998. No specific degree or field of study was mentioned.